UnitedHealth Stock (UNH) Attracts Super Investors Despite 2025 Downturn

UnitedHealth Group (UNH) has faced a brutal 2025, with shares halving from peak levels amid operational and external challenges. Yet the selloff has drawn high-profile investors, including Warren Buffett's Berkshire Hathaway, which disclosed a 5 million-share position at an average $311.97 entry point during Q2.

The stock now presents a trifecta of value propositions: institutional accumulation at depressed levels, a historically discounted valuation, and dividend appeal with a growing yield. While retail sentiment remains tepid, the Berkshire effect sparked a notable rally off recent lows.

Market observers note the divergence between technical damage and fundamental upside. UnitedHealth's healthcare infrastructure moat persists despite short-term headwinds, with the dividend growth trajectory remaining intact. The current price action echoes classic Buffett-style contrarian plays during sector dislocations.